Category: Disease States

Disease States

FDA Clears Updated bioMérieux GI Panels With Redesigned Norovirus Assay

The molecular panels feature changes to norovirus and Campylobacter detection intended to improve specificity, with results available in about one hour.

Disease States

Early Blood Test Patterns May Predict Kidney Transplant Outcomes Three Years Later

A study of more than 1,100 transplant recipients found that persistent or later-emerging elevations in donor-derived cell-free DNA were associated with greater risks of rejection and graft loss.

Disease States

Pennsylvania Law Mandates No-Cost Coverage for Colorectal Cancer Blood Tests

A new Pennsylvania law will require state-regulated insurers and Medicaid to cover blood-based colorectal cancer screening tests with no cost-sharing, Dec 21, 2026.

Cancer

Twist Bioscience Launches Custom MRD Panels for Cancer Assay Development

The new platform offers custom panel manufacturing in as little as one day to support development of tumor-informed MRD assays.

Infectious Diseases

Researchers Develop Rapid Syphilis Test That Combines Two Tests Into One

A Penn State-led team has developed a rapid syphilis test using multilayer nanoparticles, achieving up to 46% stronger signal intensity and enabling single-step detection of low antibody titers.

Womens Health

FDA Clears Point-of-Care Vaginitis PCR Panel with CLIA Waiver

The 20-minute multiplex test delivers eight results covering bacterial vaginosis, Candida species, and trichomoniasis from clinician- or self-collected swabs.

Allergy & Autoimmune

Scipher Medicine Plans Launch of Blood Test to Predict Rheumatoid Arthritis Treatment Response

The molecular test could help identify patients more likely to respond to abatacept, with early access expected in 2027.

Cardiovascular, Cerebrovascular

Labcorp and Thrive Global Launch Direct-to-Consumer Cardiometabolic Test

Labcorp and Thrive Global have launched the Thrive 5 Health Test, a direct-to-consumer panel combining five cardiometabolic biomarkers with behavioral guidance, now available through Labcorp OnDemand.

Dementias & Alzheimer’s

Diadem Secures US Patent for Blood-Based Alzheimer’s Disease Biomarker Detection

The patent expands intellectual property coverage for the blood-based assay ahead of its planned commercial launch.

Diabetes & Metabolic Diseases

Studies Identify Blood Tests That Could Reduce Need for Liver Biopsies

New findings show how blood-based biomarkers could improve detection of advanced liver disease and guide decisions about further testing.

Kidney Disease

Urine Biomarker Test Improves Prediction of Donor Kidney Outcomes

A Johns Hopkins study reports that adding three urine biomarkers to standard assessments raises the accuracy of predicting deceased donor kidney transplant success from 80% to 86%.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

Tampa General Adopts Host-Response Test After Study Shows 33% Drop in Cefepime Use

Tampa General Hospital is the first in the Southeast to implement the MeMed BV host-response test in its emergency workflow, reporting a 33% reduction in cefepime use and 13% fewer hospitalizations, according to hospital-led research.